http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5804569-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82980f9308582ae872148dad95e35c44 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-685 |
| filingDate | 1997-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1998-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34357315e39981cd48fd2b9bf727f816 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aed8a295705e6a61ffd237f71e47513b |
| publicationDate | 1998-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5804569-A |
| titleOfInvention | Exocylic-phosphoethanolamines |
| abstract | Disclosed are the use of certain cycloalkyl- and aryl-phosphoethanolamines as anti-inflammatory, anti-arrhythmic and local anesthetic agents. These therapeutically active cycloalkyl- and aryl-phosphoethanolamines are of the general Formula I:R-O-PEAIwherein R is an unsubstituted or a substituted C5-7 cycloalkyl or an unsubstituted or a substituted phenyl in which each substituent is hydrogen or an unsubstituted or substituted straight or branched C1-4 alkyl or C2-4 alkenyl, said substitution being one or more of C1-4 alkoxy, halo or cyano; and -O-PEA represents a phosphoethanolamine substituent. Also disclosed are intermediates for producing Formula I compounds. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6489369-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0013690-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0045822-A1 |
| priorityDate | 1997-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1605.